Drug Pipeline

Treosulfan Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
5
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03980769 Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating… Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder Recruiting
NCT07493538 MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity… AML Recruiting
NCT04195633 Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for… Acute Leukemia Recruiting
NCT07316595 Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome HSCT Not Yet Recruiting
NCT04994808 Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem… Acute Myeloid Leukemia Active, Not Recruiting
Sponsors Running Treosulfan Trials
Fred Hutchinson Cancer Center (3) Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1) Masonic Cancer Center, University of Minnesota (1)
Disease Areas
Leukemia (3) Acute Myeloid Leukemia (AML) (3) Myelodysplastic Syndromes (MDS) (3) Acute Lymphoblastic Leukemia (ALL) (1) Chronic Lymphocytic Leukemia (CLL) (1) Chronic Myeloid Leukemia (CML) (1) Hodgkin Lymphoma (1) Follicular Lymphoma (1) Mantle Cell Lymphoma (1)
Get alerts when Treosulfan trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free